Suppression of pulmonary innate host defence in smokers

Thorax

Volumn 64, Issue 2, 2009, Pages 144-149

  Herr, C ^a   Beisswenger, C ^a   Hess, C ^a   Kandler, K ^a   Suttorp, N ^b   Welte, T ^c   Schroeder, J M ^d   Vogelmeier, C ^a   Bals, R ^a,e  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; CATALASE; CIGARETTE SMOKE; HYDROGEN PEROXIDE; INTERLEUKIN 8; BETA DEFENSIN; DEFB4 PROTEIN, HUMAN; OXIDIZING AGENT;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; INNATE IMMUNITY; MALE; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SMOKING; SPUTUM ANALYSIS; BACTERIAL PNEUMONIA; CHEMISTRY; COMMUNICABLE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MUCOSAL IMMUNITY; PHARYNX; PSEUDOMONAS INFECTION; SPUTUM;

BETA-DEFENSINS; COMMUNITY-ACQUIRED INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; HUMANS; HYDROGEN PEROXIDE; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; MALE; MIDDLE AGED; OXIDANTS; PHARYNX; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SMOKING; SPUTUM;

EID: 60549100921     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.102681     Document Type: Article

References (35)

1. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000;342:681-9.
2. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004;164:2206-16.
3. Almirall J, Gonzalez CA, Balanzo X, et al. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 1999;116:375-9.
4. Drannik AG, Pouladi MA, Robbins CS, et al. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2004;170:1164-71.
5. Foster WM, Langenback EG, Bergofsky EH. Disassociation in the mucociliary function of central and peripheral airways of asymptomatic smokers. Am Rev Respir Dis 1985;132:633-9.
6. Raman AS, Swinburne AJ, Fedullo AJ. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest 1983;83:23-7.
7. Hodge S, Hodge G, Ahern J, et al. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2007;37:748-55.
8. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
9. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1090-5.
10. Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71.
11. Bals R. Roles of antimicrobial peptides in pulmonary disease. In: Devine DA, Hancock RE, eds. Mammalian host defence peptides. 1st ed. Cambridge: Cambridge University Press, 2004:349-74.
12. Harder J, Meyer-Hoffert U, Teran LM, et al. Mucoid Pseudomonas aeruginosa, TNF- alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000;22:714-21.
13. Welte T, Suttorp N, Marre R. CAPNETZ-community-acquired pneumonia competence network. Infection 2004;32:234-8.
14. Lieberman D, Shleyfer E, Castel H, et al. Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adults. J Clin Microbiol 2006;44:525-8.
15. Bals R, Wang X, Wu Z, et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998;102:874-80.
16. Bals R, Beisswenger C, Blouquit S, et al. Isolation and air-liquid interface culture of human large airway and bronchiolar epithelial cells. J Cyst Fibros 2004;3(Suppl 2):49-51.
17. Beisswenger C, Platz J, Seifart C, et al. Exposure of differentiated airway epithelial cells to volatile smoke in vitro. Exp Lung Res 2004;71 :402-9.
18. Harder J, Bartels J, Christophers E, et al. A peptide antibiotic from human skin. Nature 1997;387:861.
19. Chen CIU, Schaller-Bals S, Paul KP, et al. Beta-defensin and LL-37 in bronchalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros 2004;3:45-50.
20. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
21. Moser C, Weiner DJ, Lysenko E, et al. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 2002;70:3068-72.
22. Morrison G, Kilanowski F, Davidson D, et al. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun 2002;70:3053-60.
23. Fellermann K, Stange DE, Schaeffeler E, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006;79:439-48.
24. Phaybouth V, Wang SZ, Hutt JA, et al. Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model. Am J Physiol Lung Cell Mol Physiol 2006;290:L222-31.
25. Vassallo R, Tamada K, Lau JS, et al. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005;175:2684-91.
26. Glader P, Moller S, Lilja J, et al. Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells. Respir Med 2006;100:818-27.
27. Droemann D, Goldmann T, Tiedje T, et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005;6:68.
28. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
29. Valacchi G, Pagnin E, Phung A, et al. Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid Redox Signal 2005;7:25-31.
30. Lee WK, Ramanathan M Jr, Spannhake EW, et al. The cigarette smoke component acrolein inhibits expression of the innate immune components IL-8 and human beta- defensin 2 by sinonasal epithelial cells. Am J Rhinol 2007;21:658-63.
31. Laan M, Bozinovski S, Anderson GP. Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J Immunol 2004;173:4164-70.
32. MacRedmond RE, Greene CM, Dorscheid DR, et al. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 2007;8:84.
33. Tagawa Y, Hiramatsu N, Kasai A, et al. Induction of apoptosis by cigarette smoke via ROS-dependent endoplasmic reticulum stress and CCAAT/enhancer-binding protein-homologous protein (CHOP). Free Radic Biol Med 2008;45:50-9.
34. Burns AR, Hosford SP, Dunn LA, et al. Respiratory epithelial permeability after cigarette smoke exposure in guinea pigs. J Appl Physiol 1989;66:2109-16.
35. Matsushita I, Hasegawa K, Nakata K, et al. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2002;291:17-22.